Cargando…
Gentamicin, genetic variation and deafness in preterm children
BACKGROUND: Hearing loss in children born before 32 weeks of gestation is more prevalent than in full term infants. Aminoglycoside antibiotics are routinely used to treat bacterial infections in babies on neonatal intensive care units. However, this type of medication can have harmful effects on the...
Autores principales: | Bitner-Glindzicz, Maria, Rahman, Shamima, Chant, Kathy, Marlow, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984755/ https://www.ncbi.nlm.nih.gov/pubmed/24593698 http://dx.doi.org/10.1186/1471-2431-14-66 |
Ejemplares similares
-
Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study
por: Rahman, Shamima, et al.
Publicado: (2012) -
MRC ORACLE Children Study. Long term outcomes following prescription of antibiotics to pregnant women with either spontaneous preterm labour or preterm rupture of the membranes
por: Kenyon, Sara, et al.
Publicado: (2008) -
Mitochondrial m.1584A 12S m(6)(2)A rRNA methylation in families with m.1555A>G associated hearing loss
por: O'Sullivan, Mary, et al.
Publicado: (2015) -
Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
por: Norman, Jane E, et al.
Publicado: (2012) -
Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2009)